These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10562966)

  • 1. [Functional characterization of a sigma receptor and its gene expression by haloperidol].
    Nakata Y; Inoue A; Sugita S
    Nihon Yakurigaku Zasshi; 1999 Jul; 114(1):61-8. PubMed ID: 10562966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and functional characterization of a sigma receptor from rat brain.
    Seth P; Fei YJ; Li HW; Huang W; Leibach FH; Ganapathy V
    J Neurochem; 1998 Mar; 70(3):922-31. PubMed ID: 9489711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW; Cook L
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
    Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H
    J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haloperidol and reduced haloperidol on binding to sigma sites.
    Klein M; Cooper TB; Musacchio JM
    Eur J Pharmacol; 1994 Mar; 254(3):239-48. PubMed ID: 8013558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.
    Cobos EJ; del Pozo E; Baeyens JM
    J Neurochem; 2007 Aug; 102(3):812-25. PubMed ID: 17419803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent desensitization of the effects of sigma receptor ligand haloperidol in isolated rat and guinea pig hearts after chronic treatment.
    Fialova K; Krizanova O; Jarkovsky J; Novakova M
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1019-27. PubMed ID: 20029538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.
    Matsumoto RR; Bowen WD; Walker JM; Patrick SL; Zambon AC; Vo VN; Truong DD; De Costa BR; Rice KC
    Eur J Pharmacol; 1996 Apr; 301(1-3):31-40. PubMed ID: 8773444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
    Hellewell SB; Bowen WD
    Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
    Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of haloperidol-sensitive sigma-'opiate' receptors in the motor effects of antipsychotic drugs.
    Walker JM; Matsumoto RR; Bowen WD; Gans DL; Jones KD; Walker FO
    Neurology; 1988 Jun; 38(6):961-5. PubMed ID: 2897093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC
    Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors.
    Bowen WD; Moses EL; Tolentino PJ; Walker JM
    Eur J Pharmacol; 1990 Feb; 177(3):111-8. PubMed ID: 2155804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonism of opioid analgesia by a sigma system.
    Chien CC; Pasternak GW
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line.
    Ganapathy ME; Prasad PD; Huang W; Seth P; Leibach FH; Ganapathy V
    J Pharmacol Exp Ther; 1999 Apr; 289(1):251-60. PubMed ID: 10087012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells.
    Marrazzo A; Fiorito J; Zappalà L; Prezzavento O; Ronsisvalle S; Pasquinucci L; Scoto GM; Bernardini R; Ronsisvalle G
    Eur J Med Chem; 2011 Jan; 46(1):433-8. PubMed ID: 21055848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
    Hornfeldt CS; Kitto KF; Larson AA
    Eur J Pharmacol; 1996 Jun; 306(1-3):15-22. PubMed ID: 8813610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.